User menu

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial.

Bibliographic reference Coiffier, Bertrand ; Osmanov, Evgenii A ; Hong, Xiaonan ; Scheliga, Adriana ; Mayer, Jiri ; et. al. Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial.. In: The Lancet Oncology, Vol. 12, no.8, p. 773-84 (2011)
Permanent URL http://hdl.handle.net/2078.1/133833